Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer.

Breast Cancer Res Treat · 2021 · PMC8302531 · PMID 33945043

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

did not reach statistical significanceP = 0.054so close (0.05 < p ≤ 0.1)

Although patients with adjacent DCIS more often had a lower grade (grade 1 + 2 versus grade 3) of IBC, this association did not reach statistical significance ( P = 0.054).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.